Frank D’Amelio, chief financial officer of Pfizer Inc., right, arrives at Portcullis House to give evidence to Parliament’s Business, Innovation and Skills Select Committee in London, U.K., May 13, 2014. Photo: Simon Dawson/Bloomberg via Getty Images

It is now a matter of record that from the beginning of the pandemic, the U.S. Government, Mainstream Media and Big Pharma have used a massive, unprecedented fear campaign to drive the American people to line up for the deadly Covid-19 vaccine.

However, most of the tactics have run their course and virtually all who are willing to be “jabbed” at least once have done so. Not many more will submit. Logic and observable reality make it impossible to pretend the campaign is still gaining traction. Enter the next scary monster: OH MY GOD! IT’S THE DELTA VARIANT! WARN THE VILLAGE! HURRY AND GET THE BOOSTER SHOT!

According to this morning’s edition of NBC’s Today Show (July 2), the “delta variant” is now in all 50 states. The variant is thus being used to fuel the COVID hysteria needed to vaccinate the millions who are already vaccinated and keep repressive restrictions in place forever. By the way, these restrictions have bypassed legislative bodies; they are primarily pronouncements from unelected public health officials and the media or executive orders.

Several weeks ago, in the May 18 edition of The Final Call, we referenced a widely-published interview given by Pfizer’s former VP and Chief Scientist for Allergy and Respiratory division Dr. Michael Yeadon who emphatically declared: 1. Yes, the virus mutates; 2. Yes, the virus produces variants. 3. Can these variants escape your immune system? No. There is no possibility that any of the 4,000 or so variants in the public domain are going to escape immunity (become more dangerous). The most distant variant is only 0.3% different from the original sequence.


“… governments and their advisers are lying to you that variants are different enough from the current virus that, even if you’re immune from natural exposure or vaccination, you’re at risk and you need to come and get this top-up vaccine (booster shot),” he said.

Beyond the greed motive, Dr. Yeadon says this “top-up vaccine” goes “from the computer screen of a pharmaceutical company into the arms of hundreds of millions of people … Biotechnology provides you with limitless ways, frankly, to injure or kill billions of people.”

In a July 1, report by Megan Redshaw, the Children’s Health Defense cites a conflict between Pfizer, which is promising investors that booster shots will keep the billion dollar COVID revenue stream going, and a group of scientists from the Centers for Disease Control (CDC). The COVID-19 working group of the CDC’s Advisory Committee on Immunization Practices (ACIP) reported on June 23 that there is no evidence to suggest a booster is needed.

“I would have to agree with the interpretation of the working group in the sense there’s no data to support recommendations to support boosters at this time,” said Dr. Sharon Frey, a member of the ACIP and clinical director of the Center for Vaccine Development at Saint Louis University Medical School.

Dr. Grace Lee, Chair of the ACIP safety panel and professor of pediatrics at Stanford University School of Medicine, added that she would like to see more evidence of so-called “breakthrough” cases (where a vaccinated person contracts the virus) before recommending a booster shot.

“I would want greater certainty on the safety data if we’re talking about boosting before it’s clear what the risk data will look like,” she said.

Pfizer argues that boosters will be required “as antibody blood concentration wanes to ensure the broad population can’t carry the virus and thus quench the epidemic faster.” That is not the industry standard and not what the CDC is suggesting. A Pfizer spokesperson said, “we think it is possible that a third dose, a boost of our vaccine, could be needed to help provide protection against COVID-19.”

After less than one year on the market, Pfizer’s COVID-19 vaccine is the second-highest revenue-generating drug in the world (first is Humira). It may be first by the end of 2021 with a projected revenue of $26 billion for one drug in one year. This is a 70 percent increase over its original projections. The company expects to deliver 1.6 billion doses this year and is in supply talks with several countries for 2022 and beyond.

CFO Frank D’Amelio said the company sees “significant opportunity” for its vaccine once the market shifts from a “pandemic situation to an endemic situation.” This is startling when you know what an “endemic” is. While a “pandemic” is a disease that spreads across several countries and affects a very large number of people, an “endemic” is defined as follows: “a disease that is prevalent in or restricted to a particular location, region or population.” It is not hard to conclude who that particular population might be. And Pfizer has assured investors that the company will likely be able to charge more per dose than it was getting under the pandemic supply deals.

D’Amelio went on to say that Pfizer does not see vaccine demand as a onetime event, this is, in his words, “something that is going to continue for the foreseeable future.” Analysts attending the investor conference said the plan is for the COVID vaccine to be like the flu vaccine—an annual event.

Booster shots are expected to be the key revenue driver for years to come. Therefore the virus, through variants, has to continue for years to come.

And we cannot forget Moderna. Chief Commercial Officer Corinne M. LeGoff, on a call with investors in April said Americans could start getting booster shots of its vaccine later this year. “It is likely that the countries that have already achieved high vaccine coverage are going to be ready to shift their focus to boosters in 2022 and possibly even starting at the end of this year.”

America’s “top doctor,” Anthony Fauci of the National Institutes of Health, along with heads of the CDC and FDA, have relentlessly and admittedly misled the public on all aspects of the pandemic, including masks, asymptomatic transmission, immunity, social distancing, infection fatality rate, number of cases and now variants.

In the world of biology, there appears to be universal agreement among scientists that variants are not more lethal than the original virus. Sunetra Gupta, Professor of Theoretical Epidemiology, Department of Zoology at University of Oxford:

“Pathogens tend to evolve toward lower virulence because that maximizes their transmissibility … it is much more probable that these strains will not be materially so different that we would have to alter our policies.”

Dr. Claire Craig, diagnostic pathologist:

“SARS-CoV-2 genetic sequence has 30,000 letters. Alterations in a handful of letters will not change its shape much. If it did it wouldn’t function properly anyway. Fear mongering about immune escape is not needed and is irresponsible especially when no evidence supports the claims.”

In other words, the slight mutations will not impact the immune system of those who already had the virus or had prior immunity due to similar infections. Nor will they impact the vaccinated—if the vaccines are doing what their makers say they do. Otherwise, millions of people have subjected themselves to something that is not only dangerous—it doesn’t even work.